Market Cap 6.12M
Revenue (ttm) 0.00
Net Income (ttm) -38.71M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 21,500
Avg Vol 51,658
Day's Range N/A - N/A
Shares Out 4.16M
Stochastic %K 51%
Beta 2.25
Analysts Strong Buy
Price Target $25.00

Company Profile

NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer in the United States. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines. The company is developing medicines to overcome the limitations of nucleoside analogs and generate concentrations of anti-cancer metabolites in cancer cells. Its pipeline includes NUC-3373, a chemical entity derived from the nucleoside...

Industry: Biotechnology
Sector: Healthcare
Phone: 44 13 1357 1111
Address:
3 Lochside Way, Edinburgh, United Kingdom
ChickenClaw
ChickenClaw Aug. 10 at 4:49 PM
0 · Reply
Panicmode
Panicmode Aug. 10 at 4:36 PM
$NCNA when you read the history of this company you'll understand why you should stay away..
0 · Reply
Ghostalini
Ghostalini Aug. 8 at 9:45 PM
$NCNA Yes, the volume has been weak lately, but it's been more buying than selling. Remember folks... the FDA clearance of NUC-7738, the Phase Two continuation of NuTide:701 and over 21 million in capital to propel activities into 2029 are all green flags and proof that management isn't asleep at the wheel. August is looking like the month we start the upward trajectory back beyond $2. Good earnings will no doubt boost things as well.
1 · Reply
bills7765
bills7765 Aug. 8 at 4:57 PM
$NCNA i am considering upping the amount of shares I buy. Turn up the heat and really attack my avg cost. Fortune favors the bold. Its ones that lose conviction and abandon their plan that miss out. And its usually darkest an dmost desperate before dawn. Its been fun associating with you all. I have learned a lot and appreciate all your posts and comments. Even green energy 😂
0 · Reply
bills7765
bills7765 Aug. 7 at 9:07 PM
$NCNA 🤣 so much for that little increase. There are extreme forces against this stock. I am convinced they want retail to sell foe dirt cheap so they can soak up cheaper shares. If you look at the history, over the past year especially, we never really end or open green. With the exception of few days here and there. They want you to think there is 0 hope. They will not get my shares. I'll continue to soak up shares on red days. 200k volume! Someone is trying to sneak in before data drop??
1 · Reply
bills7765
bills7765 Aug. 7 at 7:07 PM
$NCNA lfggg
0 · Reply
Ghostalini
Ghostalini Aug. 7 at 6:52 PM
$NCNA Impressive candle for a Friday. More of this.
0 · Reply
Mar_3
Mar_3 Aug. 7 at 6:49 PM
0 · Reply
ChickenClaw
ChickenClaw Aug. 6 at 7:14 PM
$NCNA How Much Wood Could A WoodChuck Chuck If A WoodChuck Could Chuck Wood?
1 · Reply
FickleFin
FickleFin Aug. 6 at 9:34 AM
$NCNA delisting on the horizon. The U.S. Securities and Exchange Commission (SEC) placed a temporary stay on Nasdaq's newly approved rule that would have immediately delisted companies with a Market Value of Listed Securities (MVLS) under $5 million for 30 consecutive business.
0 · Reply
Latest News on NCNA
NuCana appoints Ian Webster as CFO

2026-06-01T12:43:48.000Z - 2 months ago

NuCana appoints Ian Webster as CFO


NuCana Appoints Ian Webster as Chief Financial Officer

Jun 1, 2026, 8:00 AM EDT - 2 months ago

NuCana Appoints Ian Webster as Chief Financial Officer


NuCana appoints Bruce as COO

2026-01-06T13:16:19.000Z - 7 months ago

NuCana appoints Bruce as COO


NuCana Appoints Theresa Bruce as Chief Operating Officer

Jan 6, 2026, 8:00 AM EST - 7 months ago

NuCana Appoints Theresa Bruce as Chief Operating Officer


NuCana presents latest clinical data at ESMO 2025 on NUC-7738

2025-12-10T13:15:35.000Z - 8 months ago

NuCana presents latest clinical data at ESMO 2025 on NUC-7738


NuCana presents data at ESMO on NUC-7738

2025-12-10T13:05:39.000Z - 8 months ago

NuCana presents data at ESMO on NUC-7738


NuCana presents data at ESMO 2025 for NUC-7738, PD-1 inhibitors

2025-10-19T21:10:12.000Z - 10 months ago

NuCana presents data at ESMO 2025 for NUC-7738, PD-1 inhibitors


NuCana announces publication of new data for NUC-3373

2025-10-14T12:16:01.000Z - 10 months ago

NuCana announces publication of new data for NUC-3373


NuCana compliant with all Nasdaq continued listing criteria

2025-09-05T12:10:43.000Z - 1 year ago

NuCana compliant with all Nasdaq continued listing criteria


NuCana Compliant with All Nasdaq Continued Listing Criteria

Sep 5, 2025, 8:00 AM EDT - 1 year ago

NuCana Compliant with All Nasdaq Continued Listing Criteria


NuCana PLC (ADR) trading halted, news pending

2025-08-08T23:50:31.000Z - 1 year ago

NuCana PLC (ADR) trading halted, news pending


NuCana announces ADS ratio change

2025-08-01T20:10:41.000Z - 1 year ago

NuCana announces ADS ratio change


NuCana Announces ADS Ratio Change

Aug 1, 2025, 4:05 PM EDT - 1 year ago

NuCana Announces ADS Ratio Change


NuCana cancels all outstanding Series A Warrants

2025-07-21T12:28:02.000Z - 1 year ago

NuCana cancels all outstanding Series A Warrants


NuCana Announces Plan to Implement ADS Ratio Change

Jul 11, 2025, 10:30 AM EDT - 1 year ago

NuCana Announces Plan to Implement ADS Ratio Change


NuCana files to sell 16.05M American Depositary Shares

2025-04-24T10:21:56.000Z - 1 year ago

NuCana files to sell 16.05M American Depositary Shares


NuCana reports  Q4  loss per share GBP (0.01) vs  GBP (.14)

2025-03-20T20:55:23.000Z - 1 year ago

NuCana reports Q4 loss per share GBP (0.01) vs GBP (.14)


NuCana Reports Q4  EPS GBP (1) vs. GBP (14)

2025-03-20T20:20:12.000Z - 1 year ago

NuCana Reports Q4 EPS GBP (1) vs. GBP (14)


NuCana reports Q3 EPS (GBP 0.07) vs (GBP 0.13) last year

2024-11-25T12:05:13.000Z - 1 year ago

NuCana reports Q3 EPS (GBP 0.07) vs (GBP 0.13) last year


Baillie Gifford's Strategic Acquisition of NuCana PLC Shares

Oct 4, 2024, 12:03 PM EDT - 2 years ago

Baillie Gifford's Strategic Acquisition of NuCana PLC Shares


NuCana to Present at the Jefferies Global Healthcare Conference

May 30, 2024, 8:36 AM EDT - 2 years ago

NuCana to Present at the Jefferies Global Healthcare Conference


NuCana Announces Listing Transfer to Nasdaq Capital Market

Nov 10, 2023, 4:01 PM EST - 2 years ago

NuCana Announces Listing Transfer to Nasdaq Capital Market


NuCana to Present at the Jefferies Healthcare Conference

Jun 1, 2023, 8:00 AM EDT - 3 years ago

NuCana to Present at the Jefferies Healthcare Conference


NuCana Announces Receipt of Nasdaq Notice

May 12, 2023, 4:01 PM EDT - 3 years ago

NuCana Announces Receipt of Nasdaq Notice


NuCana to Participate in Two Upcoming Investor Conferences

Feb 28, 2023, 8:00 AM EST - 3 years ago

NuCana to Participate in Two Upcoming Investor Conferences


NuCana Announces Receipt of NASDAQ Notice

Jan 6, 2023, 4:01 PM EST - 3 years ago

NuCana Announces Receipt of NASDAQ Notice


ChickenClaw
ChickenClaw Aug. 10 at 4:49 PM
0 · Reply
Panicmode
Panicmode Aug. 10 at 4:36 PM
$NCNA when you read the history of this company you'll understand why you should stay away..
0 · Reply
Ghostalini
Ghostalini Aug. 8 at 9:45 PM
$NCNA Yes, the volume has been weak lately, but it's been more buying than selling. Remember folks... the FDA clearance of NUC-7738, the Phase Two continuation of NuTide:701 and over 21 million in capital to propel activities into 2029 are all green flags and proof that management isn't asleep at the wheel. August is looking like the month we start the upward trajectory back beyond $2. Good earnings will no doubt boost things as well.
1 · Reply
bills7765
bills7765 Aug. 8 at 4:57 PM
$NCNA i am considering upping the amount of shares I buy. Turn up the heat and really attack my avg cost. Fortune favors the bold. Its ones that lose conviction and abandon their plan that miss out. And its usually darkest an dmost desperate before dawn. Its been fun associating with you all. I have learned a lot and appreciate all your posts and comments. Even green energy 😂
0 · Reply
bills7765
bills7765 Aug. 7 at 9:07 PM
$NCNA 🤣 so much for that little increase. There are extreme forces against this stock. I am convinced they want retail to sell foe dirt cheap so they can soak up cheaper shares. If you look at the history, over the past year especially, we never really end or open green. With the exception of few days here and there. They want you to think there is 0 hope. They will not get my shares. I'll continue to soak up shares on red days. 200k volume! Someone is trying to sneak in before data drop??
1 · Reply
bills7765
bills7765 Aug. 7 at 7:07 PM
$NCNA lfggg
0 · Reply
Ghostalini
Ghostalini Aug. 7 at 6:52 PM
$NCNA Impressive candle for a Friday. More of this.
0 · Reply
Mar_3
Mar_3 Aug. 7 at 6:49 PM
0 · Reply
ChickenClaw
ChickenClaw Aug. 6 at 7:14 PM
$NCNA How Much Wood Could A WoodChuck Chuck If A WoodChuck Could Chuck Wood?
1 · Reply
FickleFin
FickleFin Aug. 6 at 9:34 AM
$NCNA delisting on the horizon. The U.S. Securities and Exchange Commission (SEC) placed a temporary stay on Nasdaq's newly approved rule that would have immediately delisted companies with a Market Value of Listed Securities (MVLS) under $5 million for 30 consecutive business.
0 · Reply
ChickenClaw
ChickenClaw Aug. 5 at 2:38 PM
0 · Reply
FickleFin
FickleFin Aug. 5 at 2:00 PM
$NCNA never invest in biotech
0 · Reply
ExploringTrades
ExploringTrades Aug. 5 at 8:45 AM
Ticker NEXR has barely 550,000 shares outstanding. The only comparable ticker was VEEE and that one ran from 4.10$ to over 51$. NEXR released news on Aug 3rd and is shifting heavily into the AI sector. NEXR has only about 700 watchers on Stocktwits. Took a big position looking to profit massively very soon. $NCNA -- >
0 · Reply
Roronao
Roronao Aug. 4 at 9:27 PM
0 · Reply
ExploringTrades
ExploringTrades Aug. 4 at 5:59 PM
Ticker NEXR has barely 550,000 shares outstanding. The only comparable ticker was VEEE and that one ran from 4.10$ to over 51$. NEXR released news on Aug 3rd and is shifting heavily into the AI sector. NEXR has only about 700 watchers on Stocktwits. Took a big position looking to profit massively very soon. $AFRM $NCNA Watch them
0 · Reply
ExploringTrades
ExploringTrades Aug. 4 at 3:09 PM
Ticker NEXR has barely 550,000 shares outstanding. The only comparable ticker was VEEE and that one ran from 4.10$ to over 51$. NEXR released news on Aug 3rd and is shifting heavily into the AI sector. NEXR has only about 700 watchers on Stocktwits. Took a big position looking to profit massively very soon. $AFRM $NCNA ---
0 · Reply
Roronao
Roronao Aug. 4 at 9:34 AM
0 · Reply
bills7765
bills7765 Aug. 3 at 9:35 PM
$NCNA glass prolly bought on one of these ftd days
2 · Reply
ExploringTrades
ExploringTrades Aug. 3 at 9:30 PM
$NCNA 👀 Have you seen the Ebola outbreak news this weekend?? 🤯 Make sure to put VRAX onto your watchlist 💎 Ticker VRAX is one of the few bio-techs that have a solution to Ebola! I accumulated a huge amount of shares because of the recent Ebola outbreak. Numbers are rising concerningly fast. VRAX has a tiny float, great cash position and Peptides against Ebola. The right PR and it could see a big squeeze like the last time we saw an outbreak!
0 · Reply
bills7765
bills7765 Aug. 3 at 3:13 PM
$NCNA end of July filing. Could have happened months ago though. Good sign
2 · Reply
ChickenClaw
ChickenClaw Jul. 31 at 4:07 PM
0 · Reply
FickleFin
FickleFin Jul. 31 at 12:08 PM
$NCNA The Phase 2 expansion cohort of the NuTide:701 trial aims to build a robust dataset for NUC-7738 in combination with pembrolizumab (Keytruda). Enrollment Targets and ProgressTotal Recruitment Target: The clinical team is building toward an enrollment goal of up to 40 patients for this specific melanoma cohort. Current Cohort Status: According to corporate clinical tracking, the study had expanded to 21 total patients (9 newly dosed in the expansion cohort added to 12 previously treated) heading into the final push for full enrollment.
1 · Reply